Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challenge.
Identifieur interne : 002810 ( Main/Exploration ); précédent : 002809; suivant : 002811Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challenge.
Auteurs : RBID : pubmed:17998844English descriptors
- KwdEn :
- Carcinoid Tumor (pathology), Carcinoid Tumor (radiotherapy), Carcinoid Tumor (secondary), Fatal Outcome, Humans, Indium Radioisotopes (therapeutic use), Liver Neoplasms (complications), Liver Neoplasms (radiotherapy), Liver Neoplasms (secondary), Lung Neoplasms (complications), Lung Neoplasms (pathology), Male, Malignant Carcinoid Syndrome (etiology), Middle Aged.
- MESH :
- chemical , therapeutic use : Indium Radioisotopes.
- complications : Liver Neoplasms, Lung Neoplasms.
- etiology : Malignant Carcinoid Syndrome.
- pathology : Carcinoid Tumor, Lung Neoplasms.
- radiotherapy : Carcinoid Tumor, Liver Neoplasms.
- secondary : Carcinoid Tumor, Liver Neoplasms.
- Fatal Outcome, Humans, Male, Middle Aged.
Abstract
We describe a 53-year-old male patient, with a known history of metastatic carcinoid tumour of the lung, who developed a variety of symptoms of the carcinoid syndrome and subsequently a carcinoid crisis. Although bronchial carcinoid tumours are very rarely associated with symptoms of the carcinoid syndrome, a subset may develop a severe hypersecretory syndrome and exhibit an aggressive behaviour. In cases with excessive tumour load and difficult-to-control hypersecretory syndrome, management by a specialized multidisciplinary team using evidence-based regimens is mandatory to deal with the life-threatening carcinoid crisis, to improve patients' outcome and quality of life.
DOI: 10.1097/MEG.0b013e3282294d88
PubMed: 17998844
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challenge.</title><author><name sortKey="Papadogias, Dimitrios" uniqKey="Papadogias D">Dimitrios Papadogias</name><affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology and Diabetes, IASO Hospital, Athens, Greece. papadogias@gmail.com</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Endocrinology and Diabetes, IASO Hospital, Athens</wicri:regionArea></affiliation></author><author><name sortKey="Makras, Polyzois" uniqKey="Makras P">Polyzois Makras</name></author><author><name sortKey="Kossivakis, Kostantinos" uniqKey="Kossivakis K">Kostantinos Kossivakis</name></author><author><name sortKey="Kontogeorgos, George" uniqKey="Kontogeorgos G">George Kontogeorgos</name></author><author><name sortKey="Piaditis, George" uniqKey="Piaditis G">George Piaditis</name></author><author><name sortKey="Kaltsas, Gregory" uniqKey="Kaltsas G">Gregory Kaltsas</name></author></titleStmt><publicationStmt><date when="2007">2007</date><idno type="doi">10.1097/MEG.0b013e3282294d88</idno><idno type="RBID">pubmed:17998844</idno><idno type="pmid">17998844</idno><idno type="wicri:Area/Main/Corpus">002598</idno><idno type="wicri:Area/Main/Curation">002598</idno><idno type="wicri:Area/Main/Exploration">002810</idno></publicationStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Carcinoid Tumor (pathology)</term><term>Carcinoid Tumor (radiotherapy)</term><term>Carcinoid Tumor (secondary)</term><term>Fatal Outcome</term><term>Humans</term><term>Indium Radioisotopes (therapeutic use)</term><term>Liver Neoplasms (complications)</term><term>Liver Neoplasms (radiotherapy)</term><term>Liver Neoplasms (secondary)</term><term>Lung Neoplasms (complications)</term><term>Lung Neoplasms (pathology)</term><term>Male</term><term>Malignant Carcinoid Syndrome (etiology)</term><term>Middle Aged</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Indium Radioisotopes</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Liver Neoplasms</term><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Malignant Carcinoid Syndrome</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoid Tumor</term><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Carcinoid Tumor</term><term>Liver Neoplasms</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Carcinoid Tumor</term><term>Liver Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Fatal Outcome</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We describe a 53-year-old male patient, with a known history of metastatic carcinoid tumour of the lung, who developed a variety of symptoms of the carcinoid syndrome and subsequently a carcinoid crisis. Although bronchial carcinoid tumours are very rarely associated with symptoms of the carcinoid syndrome, a subset may develop a severe hypersecretory syndrome and exhibit an aggressive behaviour. In cases with excessive tumour load and difficult-to-control hypersecretory syndrome, management by a specialized multidisciplinary team using evidence-based regimens is mandatory to deal with the life-threatening carcinoid crisis, to improve patients' outcome and quality of life.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">17998844</PMID><DateCreated><Year>2007</Year><Month>11</Month><Day>13</Day></DateCreated><DateCompleted><Year>2008</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2009</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0954-691X</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>12</Issue><PubDate><Year>2007</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European journal of gastroenterology & hepatology</Title><ISOAbbreviation>Eur J Gastroenterol Hepatol</ISOAbbreviation></Journal><ArticleTitle>Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challenge.</ArticleTitle><Pagination><MedlinePgn>1154-9</MedlinePgn></Pagination><Abstract><AbstractText>We describe a 53-year-old male patient, with a known history of metastatic carcinoid tumour of the lung, who developed a variety of symptoms of the carcinoid syndrome and subsequently a carcinoid crisis. Although bronchial carcinoid tumours are very rarely associated with symptoms of the carcinoid syndrome, a subset may develop a severe hypersecretory syndrome and exhibit an aggressive behaviour. In cases with excessive tumour load and difficult-to-control hypersecretory syndrome, management by a specialized multidisciplinary team using evidence-based regimens is mandatory to deal with the life-threatening carcinoid crisis, to improve patients' outcome and quality of life.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Papadogias</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><Affiliation>Department of Endocrinology and Diabetes, IASO Hospital, Athens, Greece. papadogias@gmail.com</Affiliation></Author><Author ValidYN="Y"><LastName>Makras</LastName><ForeName>Polyzois</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Kossivakis</LastName><ForeName>Kostantinos</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Kontogeorgos</LastName><ForeName>George</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Piaditis</LastName><ForeName>George</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Kaltsas</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType>Case Reports</PublicationType><PublicationType>Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Gastroenterol Hepatol</MedlineTA><NlmUniqueID>9000874</NlmUniqueID><ISSNLinking>0954-691X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Indium Radioisotopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N">Carcinoid Tumor</DescriptorName><QualifierName MajorTopicYN="N">pathology</QualifierName><QualifierName MajorTopicYN="N">radiotherapy</QualifierName><QualifierName MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Fatal Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Indium Radioisotopes</DescriptorName><QualifierName MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName MajorTopicYN="N">complications</QualifierName><QualifierName MajorTopicYN="N">radiotherapy</QualifierName><QualifierName MajorTopicYN="Y">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName MajorTopicYN="Y">complications</QualifierName><QualifierName MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Malignant Carcinoid Syndrome</DescriptorName><QualifierName MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>2</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0b013e3282294d88</ArticleId><ArticleId IdType="pii">00042737-200712000-00022</ArticleId><ArticleId IdType="pubmed">17998844</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002810 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002810 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:17998844
|texte= Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challenge.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17998844" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a IndiumV2
| This area was generated with Dilib version V0.5.76. |  |